Carregant...
DNA Damage Does Not Cause BrdU Labeling of Mouse or Human β-Cells
Pancreatic β-cell regeneration, the therapeutic expansion of β-cell number to reverse diabetes, is an important goal. Replication of differentiated insulin-producing cells is the major source of new β-cells in adult mice and juvenile humans. Nucleoside analogs such as BrdU, which are incorporated in...
Guardat en:
| Publicat a: | Diabetes |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Diabetes Association
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6477907/ https://ncbi.nlm.nih.gov/pubmed/30833468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db18-0761 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|